-
Health Canada conditionally approves Gilead Sciences’ Lyvdelzi for PBC
22 Oct 2025 09:22 GMT
… has granted conditional approval for Gilead Sciences’ Lyvdelzi (seladelpar) for adults with … (ALP) normalisation compared to placebo.
Gilead Sciences Canada general manager Paul Petrelli …
-
Gilead Sciences patents new STAT6 ligands
20 Oct 2025 20:18 GMT
-
Gilead Sciences Breaks Out To Record Highs, The Rally Has Room To Run
19 Oct 2025 04:57 GMT
Gilead Sciences (GILD) is a top-performing … ;iStock Editorial via Getty Images Gilead Sciences (NASDAQ:GILD) is among the …
-
HBV Reactivation Risk Low After Tenofovir Cessation in HIV
22 Oct 2025 14:25 GMT
… support from Roche Diagnostics and Gilead Sciences. Bhagani reported receiving research funding … or support from AbbVie, Gilead Sciences, MSD, and ViiV/GSK …
-
Visible Longevity: Why VCs Are Betting $120 Million To Reverse Time You Can See
22 Oct 2025 14:18 GMT
… or diseased tissue. Acquired by Gilead Sciences for $4.9 billion, Forty …
-
STAT+: CVS Caremark tells AIDS activists Gilead needs to lower the price of its new HIV drug to get on formularies
22 Oct 2025 15:04 GMT
… has resisted adding a new Gilead Sciences HIV prevention drug to its …
-
Weekly Oral HIV Treatment Looks Good at Two Years
22 Oct 2025 12:51 GMT
… ’t like shots. Lenacapavir, from Gilead Sciences, works differently than other antiretrovirals …
-
Galapagos to shutter cell and gene therapy unit
22 Oct 2025 12:39 GMT
… antibody-drug conjugates (ADCs).
Meanwhile, Gilead Sciences’ Kite Pharma terminated its collaboration …
-
Generic Lenacapavir Could Help End HIV Epidemic by 2030
22 Oct 2025 12:15 GMT
… currently manufactured and marketed by Gilead Sciences, Inc.
“Lenacapavir is the closest …
-
Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock
22 Oct 2025 11:20 GMT
… programs under collaboration agreements with Gilead Sciences, Inc., Sanofi S.A. and …